Search company, investor...

Founded Year

2002

Stage

Series A | Alive

About Neurosynaptic Communications

Neurosynaptic Communications develops information and communication technologies (ICT) based products and technologies, which can create a positive impact on the global rural population. The company works in the area of data acquisition, communication, and high-end systems integration that incorporates the use of advanced sensors and embedded electronic science. It was founded in 2002 and is based in Bengaluru, India.

Headquarters Location

No. 10, Khata No. 19, 29th Main BTM Layout, II Stage, Karnataka

Bengaluru, 560 076,

India

+91-80-4131-3168

Loading...

Neurosynaptic Communications's Product Videos

Neurosynaptic Communications's Products & Differentiators

    ReMeDi(R) Managed Healthcare Services

    Set-up and End-to-End Implementation of Telemedicine Services from initial feasibility to impact assessment, with complete operationalization

Loading...

Latest Neurosynaptic Communications News

Neurosynaptic Communications Strengthens Advisory Board

Dec 20, 2016

General Neurosynaptic Communications Strengthens Advisory Board Brings on board Dr. Ashwin Naik, founder of Vaatsalya Healthcare, Mr. Amit Jain, Founder of E Health Point, Prof. (Dr.) S.V. Joga Rao as the Health Law expert and Visiting Professor in National Law School of India University, Bengaluru ? Print this article Font size - 16 + Neurosynaptic Communications , pioneers in m-health technology solutions announced the joining of Dr. S. V. Joga Rao, Dr. Ashwin Naik and Mr. Amit Jain as members of Board of Advisors. With formidable years of experience behind them, the advisory board will guide the team in paving a more affordable and accessible healthcare ecosystem in India and other developing countries. "There are numerous challenges in implementation of telemedicine,” said Sameer Sawarkar, Co-Founder, Neurosynaptic Communications. "The future can be designed if we understand the aspects of business from experts who have been on ground. I am very heartened that we are now backed by names that have carved and shaped the industry. " Dr. Ashwin Naik is the founder of Vaatsalya Healthcare, which is a winner of the Inaugural Porter Prize in India for value-based healthcare. He has also been recognized as a Young Global Leader (YGL) in 2012 by The World Economic Forum. Mr. Amit Jain is a pioneer in incubating and leading social marketing businesses in healthcare with 21 years of enriching experience. Prof. (Dr.) Joga Rao has both experience and expertise in the field of Health Law and Ethics. Prominently, he focuses on legal and ethical interface of Healthcare and Technology. He is a Max-Planck Fellow. The NCPL Advisory Board experts bring with them wealth of knowledge in corporate strategic development and technology to foster effective growth. Looking at the positive outlook of the development, Sameer Sawarkar, CEO, Neurosynaptic Communications, said ”We are honored to welcome the niche bunch of advisors with a track record of success in their fields. They bring with them a depth of business experience and leadership skills, which will help us continue evolving. With their extensive knowledge and industry experience, we are confident that they will be a valuable resource for the team. We look forward to their guidance and a fresh perspective on the brand.” Mr. Ashwin Naik, Board of Advisory, said, “Neurosynaptic Communication has been a pioneer in the field of remote and connected care, and I am excited about the new roadmap they have created. Supporting Sameer and Rajeev will be an enriching experience and I am looking forward to being part of their exciting journey, as they consolidate their position as a leader in this space.” Mr. Amit Jain, Board of Advisory, said, “I am looking forward to a fruitful association with Neurosynaptic Communication. Their approach, depth at leadership, professional acumen and intent to create a healthier nation is exceptional. Indeed, they can be a potential model for aiding in Universal Health Coverage (UHC) globally” Dr. Joga Rao, Board of Advisory, said, “Engaging in the role of advising and building NCPL, in a comprehensive sense. I am wholeheartedly dedicated to drawing on my prior experience in this sector. I am extremely delighted to be part of the advisory.” Neurosynaptic Communications has been enabling access of quality healthcare for masses to overcome healthcare challenges in the country. Most of its deployments are in the rural areas, where 70% population resides. It has enabled the largest network of centers for telemedicine in 2,200 villages with 8,000 health workers promoting public health to a population of 50 million in rural areas. NCPL currently covers 10 states in India, including Tamil Nadu, Madhya Pradesh, Andhra Pradesh, Karnataka, UP, Bihar, Rajasthan, Bengal and Tripura. ReMeDi® Technology has reduced accessibility from 4.2 kms to 3.4 kms. Services provided are 1.5 times lesser in cost than those at urban healthcare centers, leading to a healthier nation. Share this article:

Neurosynaptic Communications Frequently Asked Questions (FAQ)

  • When was Neurosynaptic Communications founded?

    Neurosynaptic Communications was founded in 2002.

  • Where is Neurosynaptic Communications's headquarters?

    Neurosynaptic Communications's headquarters is located at No. 10, Khata No. 19, 29th Main, Bengaluru.

  • What is Neurosynaptic Communications's latest funding round?

    Neurosynaptic Communications's latest funding round is Series A.

  • Who are the investors of Neurosynaptic Communications?

    Investors of Neurosynaptic Communications include Indian Angel Network, Axilor Ventures, Healthquad, e-Zest Solutions and Sunil Kant Munjal's Family Office.

  • Who are Neurosynaptic Communications's competitors?

    Competitors of Neurosynaptic Communications include iKure and 1 more.

  • What products does Neurosynaptic Communications offer?

    Neurosynaptic Communications's products include ReMeDi(R) Managed Healthcare Services and 2 more.

Loading...

Compare Neurosynaptic Communications to Competitors

M
MEngage Technologies

MEngage Technologies connects doctors with patients through a software-as-a-service (SaaS) app. The platform stores a patient's medical history on the cloud and allows doctors to manage appointments in real time, and set automated reminders. The platform also has features such as sharing prescriptions, a chat facility, and notifications and blogs that broadcast health tips. It also provides doctors with digital notepads for prescriptions.

Sevamob Logo
Sevamob

Sevamob provides an artificial intelligence (AI) assisted disease management platform. The platform uses deep learning (DL), machine learning (ML), and computer vision to predict medical conditions from symptoms, consultation for diet, point-of-care screening for blood, vision and sputum, and more. It was founded in 2014 and is based in Lucknow, India.

i
iKure

Kure provides a range of healthcare services through a combination of health outreach initiatives, skills development, and technology and health intervention programs. It addresses primary healthcare needs across rural, semi-urban, and urban areas. The company was founded in 2010 and is based in Kolkata, India.

HealthCube Logo
HealthCube

HealthCube specializes in point-of-care diagnostic devices within the healthcare technology sector. The company offers portable screening systems that can perform a variety of tests including vitals, biochemical parameters, cardiac and inflammatory markers, and infectious disease markers. These devices are designed for ease of use in remote locations without the need for electricity or internet, targeting primarily the healthcare industry. It was founded in 2015 and is based in Bethesda, Maryland.

HemoCue Logo
HemoCue

HemoCue develops, produces, and markets medical diagnostic products for Point of Care testing. The fundamental concept behind the HemoCue products is to perform important common blood and urine tests that offer lab quality results at the Point of Care without sacrificing the accuracy and precision offered by a central clinical lab. On April 10th, 2013, HemoCue was acquired by Radiometer at a valuation of $300M.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.